ArticleJournal of thoracic disease2025
Non-intubated uniportal video-assisted thoracoscopic anatomical lung volume reduction surgery-an institutional report.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Non-intubated uniportal video-assisted thoracoscopic surgery (niuVATS) lobectomy has been first reported more than a decade ago, but evidence on its feasibility in patients with severely impaired lung function remains anecdotal. We adopted the technique back in 2018 and would like to share our experience. Methods: We retrospectively investigated the outcome of niuVATS anatomical lung resection in patients with impaired lung function, defined as a predicted postoperative % of forced expiratory volume in 1 second (ppoFEV1%; <35%), that underwent surgery at Hannover Medical School between May 2018 and May 2022. Results: Fifty-seven patients underwent anatomical resection via niuVATS during the past 4 years. Of these, 12 had severely impaired lung function, and all of them were admitted for lung volume reduction surgery (LVRS) related to chronic obstructive pulmonary disease (COPD). The mean age was 65.3±11.9 years; 4 patients (33.3%) were male, and 5 (41.6%) were on presurgical oxygen supplementation therapy. Preoperative lung function was FEV1%: 30.5%±10.9%, ppoFEV1%: 25.1%±8.9%, and FEV1/forced vital capacity (FVC): 35.8%±10.6%. All patients underwent niuVATS, with no conversion to either intubation and/ or thoracotomy. Ten patients (83.3%) underwent lobectomy, and the remaining 2 patients (16.7%) underwent 3-segment resection. Six patients (50%) required a chest tube for more than 7 days (overall median drainage time was 7.5 days). All patients were discharged in good health. Eight patients (66.7%) were followed-up in Hannover Medical School, and their general conditions were good >4 months after the operation. Conclusions: Anatomical lung resection for LVRS via niuVATS may be safely feasible in certain selected patients in light of the high morbidity of this population group.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.